Information regarding the specific market share of triamcinolone ointment containing chlorofluorocarbons (CFCs) is not readily available in public domain sources.
What is Triamcinolone Ointment?
Triamcinolone is a corticosteroid used to reduce inflammation [1]. It is available in various formulations, including ointments, creams, and sprays, for treating skin conditions such as eczema, psoriasis, and dermatitis [1][2].
Why were Chlorofluorocarbons (CFCs) used in Medications?
CFCs were historically used as propellants in aerosol medications, including some topical formulations, due to their stability and effectiveness [3]. However, their use has been phased out in many applications, including pharmaceuticals, due to environmental concerns related to ozone depletion [3][4].
What is the Current Status of CFCs in Pharmaceuticals?
The Montreal Protocol, an international treaty, mandated the phase-out of ozone-depleting substances, including CFCs [4]. This led to the transition to alternative propellants in aerosol products. While specific market data for CFC-containing triamcinolone ointment is not detailed, it is likely that such formulations have been largely replaced by newer, CFC-free products [4].
Where can I find information on Drug Patents and Exclusivity?
DrugPatentWatch.com provides comprehensive data on drug patents, exclusivity periods, and market intelligence for pharmaceutical products [5]. This resource can offer insights into the patent landscape and potential competition for various drug formulations.